ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 76 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $58,490,548 | 25.26% |
Vivo Capital, LLC | 4,220,048 | $25,446,889 | 2.35% |
MPM BioImpact LLC | 2,180,864 | $13,150,610 | 2.04% |
Vestal Point Capital, LP | 3,600,000 | $21,708,000 | 1.62% |
Redmile Group, LLC | 4,036,451 | $24,339,800 | 1.47% |
Privium Fund Management B.V. | 396,966 | $2,270,646 | 0.58% |
Paradigm Biocapital Advisors LP | 1,575,605 | $9,500,898 | 0.36% |
Nan Fung Group Holdings Ltd | 41,950 | $252,959 | 0.27% |
Orbimed Advisors | 1,894,462 | $11,423,606 | 0.23% |
Affinity Asset Advisors, LLC | 100,000 | $603,000 | 0.07% |